UY27960A1 -
S - (+) - 3- (1- (2- (2,3-DIHIDRO -1H-INDOL-3-IL) ETIL) 3,6-DIHIDRO-2H-PIRIDIN-4-IL) -6-CHLORINE- 1H-INDOL AND ADDITION SLAES OF THE SAME ACID.
- Google Patents
S - (+) - 3- (1- (2- (2,3-DIHIDRO -1H-INDOL-3-IL) ETIL) 3,6-DIHIDRO-2H-PIRIDIN-4-IL) -6-CHLORINE- 1H-INDOL AND ADDITION SLAES OF THE SAME ACID.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As HfiledCriticalLundbeck & Co As H
Publication of UY27960A1publicationCriticalpatent/UY27960A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
La presente invención se refiere al compuesto de S-(+)-3-(1-(2,3-dihidro-1H-indol-3-il)3,6-dihidro-2H-piridin-4-il)-6-cloro-1H-indol que tiene la fórmula; o a una sal farmacéuticamente adeptable del mismo y a su uso para la preparación de una composición farmacéutica para el tratamiento de enfermedades y desórdenes que responden a la inhibición de la reabsorción de 5-HT y/o a las enfermedades y desórdenes que responden al antagonismo receptor de dopamina D4.The present invention relates to the compound of S - (+) - 3- (1- (2,3-dihydro-1H-indol-3-yl) 3,6-dihydro-2H-pyridin-4-yl) -6 -chloro-1H-indole having the formula; or a pharmaceutically acceptable salt thereof and its use for the preparation of a pharmaceutical composition for the treatment of diseases and disorders that respond to the inhibition of 5-HT reabsorption and / or diseases and disorders that respond to dopamine receptor antagonism D4
UY27960A2002-08-292003-08-29
S - (+) - 3- (1- (2- (2,3-DIHIDRO -1H-INDOL-3-IL) ETIL) 3,6-DIHIDRO-2H-PIRIDIN-4-IL) -6-CHLORINE- 1H-INDOL AND ADDITION SLAES OF THE SAME ACID.
UY27960A1
(en)
SUBSTITUTED DERIVATIVES OF 2-AMINO-5,6-DIHIDRO PIRIMIDIN-4 (3H) -ONAS AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING AND APPLICATIONS.
compounds for use as a therapeutically active substance; method for the treatment and / or prophylaxis of diseases that are associated with cb1 receptor modulation and use of these compounds
compound, process for its preparation, pharmaceutical composition comprising the same, use of a compound, methods for the treatment and prophylaxis of central nervous system disorders, eating disorders and obesity